Jpmorgan Chase & CO Allakos Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Allakos Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,617 shares of ALLK stock, worth $1,875. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,617
Previous 81,187 98.01%
Holding current value
$1,875
Previous $81,000 98.77%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
SELL
$0.54 - $0.92 $42,967 - $73,204
-79,570 Reduced 98.01%
1,617 $1,000
Q3 2024

Nov 08, 2024
SELL
$0.54 - $0.92 $42,967 - $73,204
-79,570 Reduced 98.01%
1,617 $1,000
Q2 2024

Dec 26, 2024
BUY
$1.0 - $1.45 $79,570 - $115,376
79,570 Added 4920.84%
81,187 $81,000
Q2 2024

Aug 12, 2024
SELL
$1.0 - $1.45 $120,005 - $174,007
-120,005 Reduced 59.65%
81,187 $81,000
Q1 2024

Dec 26, 2024
BUY
$1.02 - $3.23 $203,566 - $644,627
199,575 Added 12342.3%
201,192 $253,000
Q1 2024

May 10, 2024
BUY
$1.02 - $3.23 $156,519 - $495,643
153,450 Added 321.42%
201,192 $253,000
Q4 2023

Dec 26, 2024
BUY
$1.72 - $3.18 $79,335 - $146,677
46,125 Added 2852.5%
47,742 $130,000
Q4 2023

Feb 12, 2024
SELL
$1.72 - $3.18 $21,087 - $38,986
-12,260 Reduced 20.43%
47,742 $130,000
Q3 2023

Nov 14, 2023
BUY
$2.13 - $5.55 $11,176 - $29,120
5,247 Added 9.58%
60,002 $136,000
Q2 2023

Aug 11, 2023
BUY
$3.6 - $5.25 $185,850 - $271,031
51,625 Added 1649.36%
54,755 $238,000
Q1 2023

May 11, 2023
SELL
$4.3 - $8.27 $313,065 - $602,105
-72,806 Reduced 95.88%
3,130 $13,000
Q4 2022

Feb 13, 2023
BUY
$5.66 - $8.42 $335,519 - $499,129
59,279 Added 355.88%
75,936 $639,000
Q3 2022

Nov 14, 2022
SELL
$3.02 - $6.12 $1.81 Million - $3.67 Million
-599,168 Reduced 97.3%
16,657 $102,000
Q2 2022

Aug 11, 2022
BUY
$2.6 - $6.14 $209,188 - $494,005
80,457 Added 15.03%
615,825 $1.93 Million
Q1 2022

May 11, 2022
BUY
$5.08 - $9.81 $2.08 Million - $4.02 Million
409,478 Added 325.27%
535,368 $3.05 Million
Q4 2021

Feb 10, 2022
BUY
$8.55 - $111.89 $855,966 - $11.2 Million
100,113 Added 388.38%
125,890 $1.23 Million
Q3 2021

Nov 12, 2021
BUY
$76.53 - $110.43 $1.97 Million - $2.85 Million
25,777 New
25,777 $2.73 Million

Others Institutions Holding ALLK

# of Institutions
81
Shares Held
64.7M
Call Options Held
47.1K
Put Options Held
1K
View Full List

About Allakos Inc.

ALLK Quotes by TradingView
  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $98.3M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email